Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study
Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, Christoph Lange, Maria Musso, Fabrizio Palmieri, Valérie Pourcher, Christophe Rioux, Alena Skrahina, Nicolas Veziris, Dzmitry Viatushka, Mathilde Jachym-Fréchet, View ORCID ProfileLorenzo Guglielmetti, for the TBnet, the ESGMYC, the French MDR-TB Group
doi: https://doi.org/10.1101/2021.10.16.21265043
Simone Tunesi
1Infectious Diseases Unit, ASST Valle Olona, Busto Arsizio, Italy
Damien Le Dû
2Sanatorium, Centre Hospitalier de Bligny, Briis-sous-Forges, France
Gina Gualano
3National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy
Joan-Pau Millet
4Serveis Clínics, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain
Aliaksandr Skrahin
5The Republican Research and Practical Center for Pulmonology and TB, Minsk, Belarus
Graham Bothamley
6Homerton University Hospital, London E9 6SR, UK; Queen Mary University of London, UK; London School of Hygiene and Tropical Medicine, UK
Xavier Casas
7Serveis Clinics, Barcelona, Spain
Delia Goletti
3National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy
Christoph Lange
8Research Center Borstel, Clinical Infectious Diseases, Borstel, Germany; German Center for Infection Research (DZIF) Tuberculosis Unit, Borstel, Germany; Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany; Global TB Program, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA
Maria Musso
3National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy
Fabrizio Palmieri
3National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy
Valérie Pourcher
9APHP, Service des Maladies Infectieuses et Tropicales, Sorbonne Université, Site Pitié, Paris, France; Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Inserm UMR_S 1136, Paris, France
Christophe Rioux
10APHP, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Paris, France
Alena Skrahina
5The Republican Research and Practical Center for Pulmonology and TB, Minsk, Belarus
Nicolas Veziris
11APHP, Groupe Hospitalier Universitaire Sorbonne Université, site Saint-Antoine, Département de bactériologie, Paris, France
12APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France
13Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 13, Paris, France
Dzmitry Viatushka
5The Republican Research and Practical Center for Pulmonology and TB, Minsk, Belarus
Mathilde Jachym-Fréchet
2Sanatorium, Centre Hospitalier de Bligny, Briis-sous-Forges, France
Lorenzo Guglielmetti
12APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France
13Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 13, Paris, France
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 18, 2021.
Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study
Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, Christoph Lange, Maria Musso, Fabrizio Palmieri, Valérie Pourcher, Christophe Rioux, Alena Skrahina, Nicolas Veziris, Dzmitry Viatushka, Mathilde Jachym-Fréchet, Lorenzo Guglielmetti, for the TBnet, the ESGMYC, the French MDR-TB Group
medRxiv 2021.10.16.21265043; doi: https://doi.org/10.1101/2021.10.16.21265043
Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study
Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, Christoph Lange, Maria Musso, Fabrizio Palmieri, Valérie Pourcher, Christophe Rioux, Alena Skrahina, Nicolas Veziris, Dzmitry Viatushka, Mathilde Jachym-Fréchet, Lorenzo Guglielmetti, for the TBnet, the ESGMYC, the French MDR-TB Group
medRxiv 2021.10.16.21265043; doi: https://doi.org/10.1101/2021.10.16.21265043
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (204)
- Emergency Medicine (372)
- Epidemiology (11629)
- Forensic Medicine (10)
- Gastroenterology (684)
- Genetic and Genomic Medicine (3636)
- Geriatric Medicine (342)
- Health Economics (623)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3392)
- Nursing (193)
- Nutrition (512)
- Oncology (1782)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6030)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)